| 标题 |
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRAS(G12C) mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:The lancet. Gastroenterology & hepatology 作者:Li J; Wang Z; Huang J; Ba Y; Cao B; et al 出版日期:2026/02/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)